The first INSPIRIS RESILIA Aortic Valve^TM replacement (Edwards Lifesciences) in endocarditis

Abstract

There is an increasing number of patients who have surgery during the active phase of infective endocarditis. Despite the decreasing in-hospital mortality and increasing early intervention rate, optimal timing for surgery remains a difficult decision. For patients with mental illnesses, the choice of valve is another factor to consider as non-adherence may lead to serious adverse events Antipsychotic medications may also alter the metabolism of vitamin K antagonists increasing the risk of stroke or major haemorrhage. We report a case of a 19-year-old man with a history of Ehlers-Danlos syndrome and aortic regurgitation, who required management of aortic valve bacterial endocarditis. This is the first report describing the use of the new RESILIA INSPIRIS valve which has increased durability and does not require anticoagulation.

Keywords

Endocarditis / bio-prosthetic valve / anti-coagulation / Ehler-Danlos syndrome

References

[1] Hoen B.Clinical practice. Infective endocarditis..N Engl J Med2013;368:1425-33

[2] Liao K,Hoffman D,Frater RW.Bovine pericardium versus porcine aortic valve: comparison of tissue biological properties as prosthetic valves..Artif Organs1992;16:361-5

[3] Carpentier A,Carpentier S,Goussef N.Techniques for prevention of calcification of valvular bioprostheses..Circulation1984;70:165-8

[4] Bartuś K,Kuśmierczyk M,Bochenek M,Woźniak S,Sadowski J.Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes..Kardiol Pol2018;76:618-24

[5] Flameng W,Verbeken E.A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model..J Thorac Cardiovasc Surg2015;149:340-5

[6] Puskas JD,Svensson LG,Griffith B,Heimansohn DA,Bartus K,Rozanski J,Girardi LN,Mumtaz MA,Halkos M,Boateng P,Ryan W,Smith CR.The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue..Eur J Cardiothorac Surg2017;52:2

[7] Paradise HT,Ozonoff A,Hylek EM,Jasuja GK,Reisman JI.Outcomes of anticoagulation therapy in patients with mental health conditions..J Gen Intern Med2014;29:855-61 PMCID:PMC4026501

[8] Koertke H,Boethig D,Breymann T,Seifert D.Does the noise of mechanical heart valve prostheses affect quality of life as measured by the SF-36® questionnaire?.Eur J Cardiothorac Surg2003;24:52-7; discussion 57-8

[9] Hata R,Shinkai H.Existence of malfunctioning proα2(I) collagen genes in a patient with a proα2(I)-chain-defective variant of Ehlers-Danlos syndrome..Eur J Biochem1988;174:231-7

[10] McGhie D,Nye F.Infective endocarditis caused by Streptococcus mutans..Br Heart J1977;39:456-8 PMCID:PMC483257

[11] Weinstein AJ.Penicillin and gentamicin therapy for enterococcal infections..JAMA1973;223:1030-2